Immune Design CS (IMDZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IMDZ | AKBA | ENTA | ||
| Company | Immune Design CS | Akebia Therapeutics | Enanta Pharmaceutica | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.84 | 1.3700 | 13.46 | ||
| High | 5.85 | 1.4000 | 13.83 | ||
| Low | 5.84 | 1.3400 | 13.16 | ||
| Last | 5.85 | 1.3600 | 13.44 | ||
| Change | unch | unch | +0.12 | ||
| % Change | unch | unch | +0.90% | ||
| Volume | 103,800 | 2,006,100 | 67,100 | ||
| 20-Day Average Volume | 409,005 | 8,486,480 | 222,345 | ||
| Previous Close | 5.85 | 1.3600 | 13.32 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.84 | 1.5945 | 15.75 | ||
| 20-Day Raw Stochastic | 100.00% | 4.27% | 13.32% | ||
| 20-Day Relative Strength | 88.63% | 42.02% | 41.99% | ||
| Weighted Alpha | -20.50 | +15.27 | -49.94 | ||
| Today's Opinion | 88% Buy | 40% Buy | 40% Buy | ||
| Previous Opinion | 88% Buy | 40% Buy | 40% Buy | ||
| Last Month's Opinion | 56% Buy | 100% Buy | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 03/25/19 | -2.16% since 04/15/24 | -16.78% since 04/15/24 | ||
| Low | 5.84 on 04/01/19 | 1.3100 on 04/19/24 | 12.77 on 04/19/24 | ||
| High | 5.85 on 04/01/19 | 1.4350 on 04/18/24 | 16.13 on 04/16/24 | ||
| 1-Month | |||||
| %Chg | +0.34% since 03/01/19 | -37.33% since 03/22/24 | -7.88% since 03/22/24 | ||
| Low | 5.82 on 03/14/19 | 1.3100 on 04/19/24 | 12.77 on 04/19/24 | ||
| High | 5.85 on 04/01/19 | 2.4800 on 03/28/24 | 17.80 on 04/01/24 | ||
| 3-Month | |||||
| %Chg | +350.00% since 12/31/18 | -2.16% since 01/22/24 | +13.99% since 01/22/24 | ||
| Low | 1.22 on 01/03/19 | 1.3100 on 04/19/24 | 11.01 on 02/08/24 | ||
| High | 5.85 on 04/01/19 | 2.4800 on 03/28/24 | 17.80 on 04/01/24 | ||
| 6-Month | |||||
| %Chg | +73.08% since 10/01/18 | +63.88% since 10/20/23 | +46.09% since 10/20/23 | ||
| Low | 1.10 on 12/24/18 | 0.7801 on 10/26/23 | 8.08 on 11/10/23 | ||
| High | 5.85 on 04/01/19 | 2.4800 on 03/28/24 | 17.80 on 04/01/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 282,935 | 284,746 | 281,798 | ||
| Shares Outstanding, K | 48,365 | 209,372 | 21,156 | ||
| Annual Sales | 2,200,000 | 194,620,000 | 79,200,000 | ||
| Annual Net Income | -54,760,000 | -51,930,000 | -133,820,000 | ||
| Last Quarter Sales | 480,000 | 56,070,000 | 18,000,000 | ||
| Last Quarter Net Income | -13,600,000 | -50,000 | -33,410,000 | ||
| 60-Month Beta | 3.48 | 0.79 | 0.47 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.00 on 03/14/24 | -1.58 on 02/07/24 | ||
| Latest Earnings Date | 05/01/19 | 05/13/24 | 05/13/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||